[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642548":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":29,"responsibleParty":183,"collaborators":11,"id":185,"slug":11,"hasResults":186,"nctId":187,"briefTitle":188,"officialTitle":189,"acronym":11,"eligibilityCriteria":190,"healthyVolunteers":186,"sex":191,"minAge":192,"maxAge":11,"enrollmentInfo":193,"targetDuration":11,"studyType":196,"phases":197,"briefSummary":200,"conditions":201,"keywords":203,"overallStatus":212,"whyStopped":11,"lastUpdateSubmitDate":213,"lastUpdatePostDateStruct":214,"startDateStruct":217,"completionDateStruct":219,"leadSponsor":221,"locationsCount":222},{"fullName":5,"class":6},"Jacobio Pharmaceuticals Co., Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Dose escalation\u002Fbackfill","EXPERIMENTAL",null,[13],"Drug: JAB-23E73 tablet，nab-paclitaxel，gemcitabine",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DRUG","JAB-23E73 tablet，nab-paclitaxel，gemcitabine","Orally, intravenous (IV) infusion",[9],[21],{"name":22,"affiliation":22,"role":23},"Jacobio Pharmaceuticals","STUDY_DIRECTOR",[25],{"name":22,"role":26,"phone":27,"phoneExt":11,"email":28},"CONTACT","86 10 56315466","clinicaltrials@jacobiopharma.com",[30,46,60,69,81,93,105,119,131,143,152,162,174],{"facility":31,"status":11,"city":32,"state":33,"zip":34,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Beijing Cancer Hospital","Beijing","Beijing Municipality","100142","China",{"type":37,"coordinates":38},"Point",[39,40],116.39723,39.9075,{"lat":40,"lon":39},[43],{"name":31,"role":26,"phone":44,"phoneExt":11,"email":45},"86+13911219511","doctorshenlin@sina.com",{"facility":47,"status":11,"city":48,"state":49,"zip":50,"country":35,"cosmosGeoPoint":51,"geoPoint":55,"contacts":56},"Zhejiang Cancer Hospital","Hangzhou","Zhejiang","310005",{"type":37,"coordinates":52},[53,54],120.16142,30.29365,{"lat":54,"lon":53},[57],{"name":47,"role":26,"phone":58,"phoneExt":11,"email":59},"86+13858195803","hzyingjieer@163.com",{"facility":61,"status":11,"city":32,"state":11,"zip":11,"country":35,"cosmosGeoPoint":62,"geoPoint":64,"contacts":65},"Beijing Tsinghua Changgung Hospital",{"type":37,"coordinates":63},[39,40],{"lat":40,"lon":39},[66],{"name":61,"role":26,"phone":67,"phoneExt":11,"email":68},"86+13366152815","joelbmu@126.com",{"facility":70,"status":11,"city":71,"state":11,"zip":11,"country":35,"cosmosGeoPoint":72,"geoPoint":76,"contacts":77},"Hunan Cancer Hospital","Changsha",{"type":37,"coordinates":73},[74,75],112.97087,28.19874,{"lat":75,"lon":74},[78],{"name":70,"role":26,"phone":79,"phoneExt":11,"email":80},"86+18673181133","liuzhenyang@hnca.org.cn",{"facility":82,"status":11,"city":83,"state":11,"zip":11,"country":35,"cosmosGeoPoint":84,"geoPoint":88,"contacts":89},"Harbin Medical University Cancer Hospital","Harbin",{"type":37,"coordinates":85},[86,87],126.65,45.75,{"lat":87,"lon":86},[90],{"name":82,"role":26,"phone":91,"phoneExt":11,"email":92},"86+13845120210","yanqiaozhang@126.com",{"facility":94,"status":11,"city":95,"state":11,"zip":11,"country":35,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Jiangsu Province Hospital","Nanjing",{"type":37,"coordinates":97},[98,99],118.77778,32.06167,{"lat":99,"lon":98},[102],{"name":94,"role":26,"phone":103,"phoneExt":11,"email":104},"86+13585172066","Xiaofengch198019@126.com",{"facility":106,"status":11,"city":107,"state":11,"zip":11,"country":35,"cosmosGeoPoint":108,"geoPoint":112,"contacts":113},"Shanghai Jiaotong University School of Medicine Ruijin Hospital","Shanghai",{"type":37,"coordinates":109},[110,111],121.45806,31.22222,{"lat":111,"lon":110},[114],{"name":115,"role":26,"phone":116,"phoneExt":117,"email":118},"Shanghai Jiaotong University School of Medicine Ruijin Hospita","86+","86+13901943778","shenby@shsmu.edu.cn",{"facility":120,"status":11,"city":121,"state":11,"zip":11,"country":35,"cosmosGeoPoint":122,"geoPoint":126,"contacts":127},"ShanXi Cancer Hospital","Taiyuan",{"type":37,"coordinates":123},[124,125],112.56028,37.86944,{"lat":125,"lon":124},[128],{"name":120,"role":26,"phone":129,"phoneExt":11,"email":130},"86+13811176181","WXCAMS@126.com",{"facility":132,"status":11,"city":133,"state":11,"zip":11,"country":35,"cosmosGeoPoint":134,"geoPoint":138,"contacts":139},"Hubei Province Hospital","Wuhan",{"type":37,"coordinates":135},[136,137],114.26667,30.58333,{"lat":137,"lon":136},[140],{"name":132,"role":26,"phone":141,"phoneExt":11,"email":142},"86+15629019627","971070316@qq.com",{"facility":144,"status":11,"city":133,"state":11,"zip":11,"country":35,"cosmosGeoPoint":145,"geoPoint":147,"contacts":148},"Wuhan Union Hospital Of China",{"type":37,"coordinates":146},[136,137],{"lat":137,"lon":136},[149],{"name":144,"role":26,"phone":150,"phoneExt":11,"email":151},"86+13720117761","heshuiwu@hust.ed.cn",{"facility":153,"status":11,"city":133,"state":11,"zip":11,"country":35,"cosmosGeoPoint":154,"geoPoint":156,"contacts":157},"Zhongnan Hospital of Wuhan University",{"type":37,"coordinates":155},[136,137],{"lat":137,"lon":136},[158],{"name":153,"role":26,"phone":159,"phoneExt":160,"email":161},"86+13971235235","86-13971235235","pjxp888@126.com",{"facility":163,"status":11,"city":164,"state":11,"zip":11,"country":35,"cosmosGeoPoint":165,"geoPoint":169,"contacts":170},"Henan Cancer Hospital","Zhengzhou",{"type":37,"coordinates":166},[167,168],113.64861,34.75778,{"lat":168,"lon":167},[171],{"name":163,"role":26,"phone":172,"phoneExt":11,"email":173},"86+13937100233","2290773710@qq.com",{"facility":175,"status":11,"city":164,"state":11,"zip":11,"country":35,"cosmosGeoPoint":176,"geoPoint":178,"contacts":179},"The First Affiliated hospital of Zhengzhou University",{"type":37,"coordinates":177},[167,168],{"lat":168,"lon":167},[180],{"name":175,"role":26,"phone":181,"phoneExt":11,"email":182},"86+13676932999","yanruqin@163.com",{"type":184,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100642548",false,"NCT07640295","Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations","A Multicenter, Phase Ib\u002FIII Study to Evaluate JAB-23E73 in Combination With Nab-Paclitaxel and Gemcitabine in Participants With Metastatic Pancreatic Ductal Adenocarcinoma Harboring KRAS Gene Alterations","Inclusion Criteria:\n\n1.Written informed consent signed by the participant or the participant's legally authorized representative must be obtained prior to performing any study-related procedures. 2. Histologically or cytologically confirmed metastatic PDAC.\n\n3\\. No prior systemic antitumor therapy for advanced disease (treatment-naïve). 4. Presence of KRAS gene alterations: be enrolled upon approval by the sponsor).\n\n5\\. ECOG performance status score of 0 or 1. 6. Adequate organ function.\n\nExclusion Criteria:\n\n1. Inability to swallow oral medications or the presence of gastrointestinal dysfunction or disease that may significantly alter drug absorption.\n2. A history of another malignancy within 2 years prior to the first dose, histologically distinct from the cancer under study, except for carcinoma in situ of the cervix, superficial non-invasive bladder cancer, or adequately treated stage I non-melanoma skin cancer.\n3. Prior treatment with KRAS G12C inhibitors, KRAS G12D inhibitors, pan-KRAS inhibitors, or other agents of the same class.\n4. Primary central nervous system (CNS) tumors.\n5. Women who are pregnant or breast-feeding.\n6. Participants who have progressive disease or recurrence during neoadjuvant or adjuvant treatment, or within 6 months after the last dose of medication.","ALL","18 Years",{"count":194,"type":195},80,"ESTIMATED","INTERVENTIONAL",[198,199],"PHASE1","PHASE2","The purpose of this study is to determine the safety and efficacy of pan KRAS inhibitor JAB-23E73 in combination with nab-paclitaxel and gemcitabine in participants with metastatic PDAC harboring KRAS gene alterations.",[202],"Metastatic Pancreatic Ductal Adenocarcinoma",[204,205,206,207,208,209,210,211],"KRAS","KRAS mutation","KRAS G12C, KRAS G12D, KRAS G12V, KRAS G12S, KRAS G12A,","Pan-KRAS","Pancreatic ductal adenocarcinoma","KRAS-mutant tumor","Targeted Therapy","JAB-23E73","NOT_YET_RECRUITING","2026-06-08",{"date":215,"type":216},"2026-06-10","ACTUAL",{"date":218,"type":195},"2026-06-22",{"date":220,"type":195},"2030-12-31",{"name":5,"class":6},13]